Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats

查看全文 作　　者：Gang [1]CHENG;Geng [1]XU;Hong-wen [1]CAI;Hui-hua [2]WANG;Xiao-feng [3]BAO

机构地区：[1]Departments of Cardiology, the Second Affiliated Hospital, Zhejiang University, Medical School,Hangzhou 310009, China;[2]Departments of Anesthesiology , the Second Affiliated Hospital, Zhejiang University, Medical School,Hangzhou 310009, China;[3]Departments of Ultrosonography, the Second Affiliated Hospital, Zhejiang University, Medical School,Hangzhou 310009, China

出　　处：《Acta Pharmacologica Sinica》索引2007年第28卷第4期,共7页

基　　金：Research Funding for Distinguished Young Scholars in Medicine of Zhejiang Province,China(№ 2004QN011) 摘　　要：目的:那 atorvastatin 与 non-ischemic etiology.Methods 在 heartfailure 禁止 MMP-2 和 9 表示在 volume-overload-induced heartfailure 上检验 atorvastatin 的角色并且测试假设:动静脉( AV )对待管的老鼠是 administeredwith atorvastatin ( 3 mg ·k g^(为 17 weeks.Ventricular 肥大和 heartfailure 的 -1)·d^(-1))or 车辆被 echocardiography 估计,B类型 natriuretic 肽 BNP mRNA 水平 andmorphological measurement.MMP-2,9 关键词：大鼠阿托伐他汀非缺血性心力衰竭基质金属蛋白酶-2 基质金属蛋白酶-9

相关文献

参考文献（35）
引证文献（7）
耦合文献（0）

参考文献(35)

引证文献(7)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats

参考文献(35)

引证文献(7)

用户提示